Startups
CytImmune is a biotechnology company that has invented, patented, and developed a set of novel technologies with the potential to treat up to 85% of all cancers. Our IO+ platform turns hot tumors cold, remodels the tumor microenvironment, and kills cancer cells.
Overview
Location
United States, Maryland, Rockville
Employees
11-50
Total raised
$1M
Founded date
2005
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 20, 2011 | The FDA and nanotechnology: Developing medicine on a case-by-case basis | Nanomedicine offers the promise of new drugs with targeted delivery and fewer side effects, but the companies developing such medicines encounter a challenge: The U.S. Food and Drug Administration has no official definition of nanotechnolog... |
| May 19, 2011 | Nanomedicine, the FDA: Developing science on a case-by-case basis | The still-developing regulations for nanomedicines was the topic of the latest NanoBio Executive Roundtable, a series of panel discussions presented by the Center of Innovation for Nanobiotechnology, or COIN. Katherine Tyner, a chemist in t... |
| CytImmune raising $1M for cancer treatment using gold nanoparticles | Nanomedicine company CytImmune disclosed in a recent U.S. Securities and Exchange Commission filing that it’s raising up to $1 million for its experimental cancer treatment, which uses nanoparticles of gold to deliver potent chemotherapy dr... | |
| Nanomedicine, the FDA: Developing science on a case-by-case basis | Nanomedicine offers the promise of new drugs with targeted delivery and fewer side effects, but the companies developing such medicines encounter this challenge: The U.S. Food and Drug Administration has no official definition of nanotechno... |
Reviews 0
FAQ about Cytimmune Sciences
When was Cytimmune Sciences founded?
Cytimmune Sciences was founded in 2005.
How much funding has Cytimmune Sciences raised?
Cytimmune Sciences has raised $1M in total across 1 funding round.
What has the press written about Cytimmune Sciences?
Parsers VC has collected 5 articles mentioning Cytimmune Sciences, among them “The FDA and nanotechnology: Developing medicine on a case-by-case basis” (May 20, 2011) and “Nanomedicine, the FDA: Developing science on a case-by-case basis” (May 19, 2011).
Is Cytimmune Sciences still active?
Yes, Cytimmune Sciences is active; its latest activity on Parsers VC dates from Mar 8, 2012.